AI
ABMD

Atom Investors’s Abiomed Inc ABMD Stock Holding History

Atom Investors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,742
Closed -$483K – 628
2020
Q3 		$483K Buy
+1,742
New +$502K 0.05% 258
2019
Q3 		– Sell
-949
Closed -$247K – 467
2019
Q2 		$247K Sell
949
-437
-32% -$116K 0.02% 366
2019
Q1 		$396K Buy
+1,386
New +$461K 0.03% 379

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Atom Investors's ABMD Position: Q4 2020 in Review

Atom Investors sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 1,742 shares — an estimated $483K sold.

Atom Investors first reported a position in ABMD in Q1 2019 and held it in 3 quarters. The position peaked at $483K in Q3 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • Atom Investors reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
  • Atom Investors sold 1,742 Abiomed Inc shares in Q4 2020, an estimated $483K.
  • Atom Investors first reported a position in Abiomed Inc in Q1 2019 and held it in 3 quarters.
  • Atom Investors's Abiomed Inc position peaked at $483K in Q3 2020.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Atom Investors's 13F filing for Q4 2020, filed 16 Feb 2021.